Merger And Acquisition Of Chinese Pharmaceutical Enterprises And Influencing Factors Of Performance Evaluation

Merger and acquisition are an important way of business growth. Throughoutmost of history, the world ranking of multinational pharmaceutical companies havecarried out different scale merger and acquisition, along with the deepening of reformand opening up and rapid development of Chinese pharmaceutical industry,pharmaceutical industry in China will inevitably face the problem of resourceintegration and restructuring. In recent years, a variety of new types of alliances,merger and acquisition and restructuring to become Chinese pharmaceuticalenterprises to expand business scale, backward enterprises to improve the industrialstructure of a major means to play a role, however, Chinese pharmaceuticalenterprises merger and acquisition transactions showing a success rate year by yearrise and efficiency is not satisfactory after the merger and reorganization of thephenomenon. Based on the review of relevant theories on merger and acquisition,combined with the status quo of Chinese pharmaceutical enterprises merger andacquisition, dynamic factor because, problems, etc., select the Tianjin PharmaceuticalGroup Company M&A M’s case, the introduction of the Balanced Scorecard thinkingin-depth study of factors that affect the success of Chinese pharmaceutical enterprisesmerger and acquisition were discussed, and put forward Chinese pharmaceuticalenterprises to help the success rate of merger and acquisition advice.Factors that affect the success of the merger and reorganization of Chinesepharmaceutical enterprises can be divided into factors influencing factors affectingmerger and acquisition transactions and merger and acquisition integration reached:(1)In the process of merger and acquisition transactions, the main factors affectingbusiness development strategy, the target company’s valuation and M&Arestructuring plan, Which play a fundamental role in the development strategy, thevaluation of the target company is an important preparatory stage, merger andacquisition in the payment plan, the purchase price, the results of the target company’ssize and arrangements will affect employees of the target company’s merger andacquisition.(2) In merger and acquisition integration phase, the integration processfrom business development strategy, assets, business, cultural and other areas in orderto influence the outcome of corporate merger and acquisition, and pharmaceutical companies with particular emphasis on the integration of intangible assets. M&Aactivities in Chinese pharmaceutical enterprises, must depart from the strategic goals,merger and acquisition to develop a reasonable plan, careful valuation of the targetcompany, and the importance of post-merger integration restructuring.